Pharmaceutical

Tempero secures $70m to advance addiction treatment candidate

TMP-301 is being investigated in clinical trials for alcohol use disorder and cocaine use disorder.

Mar 25, 2025 - 06:00
Tempero secures $70m to advance addiction treatment candidate
TMP-301 is being investigated in clinical trials for alcohol use disorder and cocaine use disorder.
Read the original article

Tags:

Previous Article

Sermonix and Regor to enhance breast cancer treatment options

Next Article

Valneva outlays 40,000 vaccines to Réunion amidst chikungunya surge

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

The benefits of using a nimble platform from phase to phase

The benefits of using a nimble platform from phase to p...

Oct 6, 2024

Alvotech and Bioventure gain approval for Humira biosimilar in Egypt

Alvotech and Bioventure gain approval for Humira biosim...

Aug 30, 2023

STAT+: Lobbying spending dropped for companies that departed PhRMA

STAT+: Lobbying spending dropped for companies that dep...

Jul 24, 2023